- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05502536
Effects of Fairytales on Preschool Children With Attention Deficit Hyperactivity Disorder
Effects of Individualized Fairytales on Preschool Children With Attention Deficit Hyperactivity Disorder With Developmental Delay
Study Overview
Status
Intervention / Treatment
Detailed Description
Thirty preschool children with Attention Deficit Hyperactivity Disorder and developmental delays will be enrolled in regular traditional rehabilitation programs.
They will be randomized to the intervention group and control group. The participants in the intervention group will receive an additional 30 minutes per week for 12 sessions of individualized fairytales classes by a child and educational teacher for three months. The participants of both groups will continue to receive the traditional rehabilitation programs.
Therapeutic effects, including attention, cognitive function, vocabulary function, physical functional performance, and quality of life at baseline, will be evaluated after 12 weeks of treatment and three months after the treatment.
The evaluator will be blinded to the group's allocation during the whole course of the intervention.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 111-01
- Shin Kong Wu Ho-Su Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- preschool children with a diagnosis of Attention Deficit Hyperactivity Disorder and developmental delay, under regular traditional rehabilitation programs, intelligence quotient 70 or greater
Exclusion Criteria:
- age less than 3 or greater than 6 of children diagnosed with Attention Deficit Hyperactivity Disorder and developmental delay, under regular traditional rehabilitation programs, intelligence quotient below 70
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention group
traditional rehabilitation programs with additional individualized fairytales class
|
In addition to traditional rehabilitation programs, 30 minutes per week for 12 sessions of individualized fairytales classes by a child and educational teacher for three months, to preschool children with Attention Deficit Hyperactivity Disorder and developmental delays in regular traditional rehabilitation programs
|
|
NO_INTERVENTION: Control group
traditional rehabilitation programs without additional individualized fairytales class
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes of hyperactivity
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score assessed by Swanson, Nolan and Pelham questionnaire, higher score indicating greater hyperactivity
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
changes of attention
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score change by Conners Kiddie Continuous Performance Test, greater score indicating lower attention span
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change of vocabulary
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score change by Receptive and Expressive Vocabulary Test, higher score indicating greater performance
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of sensory integration
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score change by Sensory Profile, 0-100, higher score indicating better sensory profile
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of intelligence
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score change by Wechsler Intelligence Scale for Children, the average score is 100, with a higher score indicating higher intelligence and a lower score indicating a lower level of intelligence
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of physical functional performance
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score assessed by Pediatric Outcome Data Collection Instrument, 0-100, a higher score indicating greater performance
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of quality of life
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score assessed by the Pediatric Quality of Life Inventory, 0-100, a higher score indicating a greater quality of life
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of family impact
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
score assessed by Child Health Questionnaire, parent form 28, 0-100, a higher score indicating better performance
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of walking time
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
walking time
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of stairs climbing time
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
climbing time
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of balance
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
one leg standing time
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
|
change of physical function
Time Frame: score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
5 times sit to stand up
|
score change from baseline to 12 weeks of treatment, and 12 weeks after treatment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022SKHADR033
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Central South UniversityRecruitingAttention-Deficit/Hyperactivity DisorderChina
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
Clinical Trials on Traditional rehabilitation programs with Individualized fairytales class
-
Taipei Medical UniversityNot yet recruitingDevelopmental Delays | Attention Deficit Hyperactivity DisordersTaiwan
-
Hama UniversityRecruitingMalocclusion | Class II MalocclusionSyria
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedDistal Radius FractureChina
-
Cairo UniversityEnrolling by invitationCoronary Artery Bypass Grafting | Post Coronary Artery Bypass GraftingEgypt
-
Peking University Third HospitalBeihang UniversityCompleted
-
Centre Hospitalier Universitaire de NiceCompleted
-
Sherin Hassan Mohammed MehaniCompletedMechanical Ventilation ComplicationEgypt
-
Beni-Suef UniversityNot yet recruitingSternal Instability After Median SternotomyEgypt
-
IRCCS National Neurological Institute "C. Mondino...CompletedParkinson's Disease
-
KTO Karatay UniversityMEDICANA HOSPITAL, ANKARACompletedTemporomandibular Joint Disorders | Pelvic Floor Disorders | TinnitusTurkey